DAWEX
8.2.2024 08:31:33 CET | Business Wire | Press release
Today marks the signature of Data4Industry-X, the trusted, secure, compliant and sovereign data exchange environment for the Industry sector, under the control of the industry. Initially addressing the automotive and power generation industry challenges, the solution Data4Industry-X aims at improving competitiveness and reducing the carbon footprint of major global industrial organizations with operations spread across multiple countries. Data4Industry-X will enable organizations to innovate and operate services on distributed data, coming from various factories, organizations or countries, while keeping control over the data produced locally and abroad.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240205958581/en/
The Trusted Data Exchange Solution for Industry (Credits: Dawex)
Supported by the French government’s France 2030 initiative and the European program Next Generation1, and with the endorsement of AIF (Alliance pour l’industrie du futur), Data4Industry-X relies on the technological and industrial expertise of Dawex, Schneider Electric, Valeo, CEA, and Prosyst to deliver a powerful response to support the Industry digital transformation and capitalize on the high potential of industrial data.
Contributing to the international Manufacturing-X initiative, Data4Industry-X is a trusted and secure data exchange solution, implementing the Gaia-X de facto standards and designed in compliance with the new European data regulations, such as the Data Act.
Addressing the Industry challenge of data exchange in decentralized manufacturing, Data4Industry-X will improve efficiency and productivity, accelerate data-driven innovation, boost competitiveness and minimize carbon footprint.
In a context of heavy digital transformation and industrial sovereignty, Data4Industry-X will contribute to improving Europe’s competitiveness to ultimately foster a compelling and sustainable Industry ecosystem by leveraging the full potential of broad cross-border, cross-company, cross-factory industrial data exchanges.
“The Industry sector is a strategic pillar to the European and global economy. Accelerating data exchange across trusted data spaces will definitely have a transformative impact on industrial organizations, driving innovation and responsible growth,” said Laurent Lafaye, Dawex co-CEO. “We are extremely happy to bring Dawex technology and expertise to the deployment of Data4Industry-X, and empower the Industry to foster a resilient and sustainable Industry ecosystem,” concluded Mr. Lafaye.
“Trusted data exchange is fundamental to driving collaboration, forging partnerships, and establishing new industrial models. Those new digital models are essentials for accelerating the transformation toward a more resilient, sustainable, and high-performing industrial eco-system. Schneider Electric takes pride in contributing with our industrial digital transformation expertise to develop Data4Industry-X as a flagship project of International Manufacturing-X,“ said Marc LAFONT, Innovation and Upstream Marketing VP, Industrial Automation Business Unit, Schneider Electric.
Romain Bruniaux, VP Industry, Valeo said: “Data4Industry-X is a collaborative trusted and secure data exchange solution, It offers amazing opportunities to speed up digitalization of our manufacturing process while drastically reducing our scope 1 & 2 CO2 direct and indirect emissions. With Data4Industry-X, Valeo will have the necessary data to support and direct its actions to meet our commitment to be carbon neutral by 2050.”
“Data4Industry-X capitalizes on national technologies that have already proved their worth in industry. Given the international state of the art in the field, with few operational tools known to date, Europe has a chance to take the lead in data exchange for Manufacturing,” said Alexandre Bounouh, Director CEA List, Carnot Institute.
“Collective intelligence, shared vision, teams’ symbiosis: the ingredients come together for the success of Data4Industry-X,” says Abdallah Asse, Prosyst CEO.
About Dawex
Dawex is the leader in data exchange solutions to distribute or share data products, with trust, for any business case. With the Dawex solution Data Exchange Platform, organizations create data ecosystems based on data marketplaces and data hubs that meet regulatory requirements, address traceability and security challenges. Awarded Technology Pioneer by the World Economic Forum, Dawex is the initiator of an international standardization program on “Trusted Data Transaction”. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.
About Schneider Electric
Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
About Valeo
As a technology company and partner to all automakers and new mobility players, Valeo is innovating to make mobility cleaner, safer and smarter. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group's growth drivers. Learn more: https://www.valeo.com/en/
About CEA-List
The CEA-List, based in Paris-Saclay and Grenoble, is a CEA technology research institute dedicated to intelligent digital systems. From artificial intelligence to digital trust, its research applies to a wide range of fields, from the industry of the future to digital health, contributing to the industrial competitiveness of its partners through innovation and technology transfer. CEA-List has been a "Carnot Institute" since 2006. Learn more: https://www.cea.fr/english
About Prosyst
Prosyst develops and markets innovative solutions (hardware and software) stimming from its strong commitment in Research and Development and offers global approaches for design, setup, simulation, data collect and management, diagnosis and performance, to support its customers all along the automated systems life cycle. Prosyst addresses all sectors of activity and counts among others, clients like Stellantis, Renault, SNCF, EDF, Naval Group, … Learn more: https://www.prosyst.fr/
1Supported by the European Union - Next Generation EU “France Relance” program
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240205958581/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom